{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:09:42Z","timestamp":1768003782280,"version":"3.49.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.1093\/ndt\/gfh763","type":"journal-article","created":{"date-parts":[[2005,4,13]],"date-time":"2005-04-13T04:12:23Z","timestamp":1113365543000},"page":"1083-1092","source":"Crossref","is-referenced-by-count":56,"title":["Prolonged treatment of refractory Wegener's granulomatosis with 15-deoxyspergualin: an open study in seven patients"],"prefix":"10.1093","volume":"20","author":[{"given":"Wilhelm H.","family":"Schmitt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Birck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Heinzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"G\u00f6bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mira","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Warnatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans H.","family":"Peter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fokko J.","family":"van der Woude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,4,12]]},"reference":[{"key":"key\n\t\t\t\t20171012170343_BIB1","doi-asserted-by":"crossref","unstructured":"Hoffman GS, Kerr GS, Leavitt RY et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med1992; 116: 488\u2013498","DOI":"10.7326\/0003-4819-116-6-488"},{"key":"key\n\t\t\t\t20171012170343_BIB2","doi-asserted-by":"crossref","unstructured":"Takeuchi T, Iinuma H, Kunimoto S et al. A new antitumor antibiotic, spergualin: isolation and antitumor activity. J Antibiot (Tokyo)1981; 34: 1619\u20131621","DOI":"10.7164\/antibiotics.34.1619"},{"key":"key\n\t\t\t\t20171012170343_BIB3","doi-asserted-by":"crossref","unstructured":"Stegeman CA, Birck R. New immunosuppressants: mycophenolate and 15-deoxyspergualin. In: Kallenberg CGM, Cohen Tervaert JW, eds, Disease-Modifying Therapy in the Vasculides. Birkh\u00e4user Verlag, Basel: 2001; 125\u2013146","DOI":"10.1007\/978-3-0348-8235-4_7"},{"key":"key\n\t\t\t\t20171012170343_BIB4","doi-asserted-by":"crossref","unstructured":"Holcombe H, Mellman I, Janeway CA Jr, Bottomly K, Dittel BN. The immunosuppressive agent 15-deoxyspergualin functions by inhibiting cell cycle progression and cytokine production following naive T cell activation. J Immunol2002; 169: 4982\u20134989","DOI":"10.4049\/jimmunol.169.9.4982"},{"key":"key\n\t\t\t\t20171012170343_BIB5","doi-asserted-by":"crossref","unstructured":"Tepper MA, Nadler SG, Esselstyn JM, Sterbenz KG. Deoxyspergualin inhibits kappa light chain expression in 70Z\/3 pre-B cells by blocking lipopolysaccharide-induced NF-kappa B activation. J Immunol1995; 155: 2427\u20132436","DOI":"10.4049\/jimmunol.155.5.2427"},{"key":"key\n\t\t\t\t20171012170343_BIB6","doi-asserted-by":"crossref","unstructured":"Wang B, Benoist C, Mathis D. The immunosuppressant 15-deoxyspergualin reveals commonality between preT and preB cell differentiation. J Exp Med1996; 183: 2427\u20132436","DOI":"10.1084\/jem.183.6.2427"},{"key":"key\n\t\t\t\t20171012170343_BIB7","doi-asserted-by":"crossref","unstructured":"Okubo M, Tamura K, Kamata K et al. 15-Deoxyspergualin \u2018rescue therapy\u2019 for methylprednisolone-resistant rejection of renal transplants as compared with anti-T cell monoclonal antibody (OKT3). Transplantation1993; 55: 505\u2013508","DOI":"10.1097\/00007890-199303000-00010"},{"key":"key\n\t\t\t\t20171012170343_BIB8","doi-asserted-by":"crossref","unstructured":"Hotta O, Furuta T, Chiba S, Yusa N, Taguma Y. Immunosuppressive effect of deoxyspergualin in proliferative glomerulonephritis. Am J Kidney Dis1999; 34: 894\u2013901","DOI":"10.1016\/S0272-6386(99)70048-X"},{"key":"key\n\t\t\t\t20171012170343_BIB9","doi-asserted-by":"crossref","unstructured":"Amemiya H. Deoxyspergualin: clinical trials in renal graft rejection. Japan Collaborative Transplant Study of Deoxyspergualin. Ann NY Acad Sci1993; 685: 196\u2013201","DOI":"10.1111\/j.1749-6632.1993.tb35865.x"},{"key":"key\n\t\t\t\t20171012170343_BIB10","doi-asserted-by":"crossref","unstructured":"Birck R, Warnatz K, Lorenz HM et al. 15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy. J Am Soc Nephrol2003; 14: 440\u2013447","DOI":"10.1097\/01.ASN.0000048716.42876.14"},{"key":"key\n\t\t\t\t20171012170343_BIB11","doi-asserted-by":"crossref","unstructured":"Schmitt WH, Hagen EC, Neumann I, Nowack R, Flores-Suarez LF, van der Woude FJ. Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int2004; 65: 1440\u20131448","DOI":"10.1111\/j.1523-1755.2004.00534.x"},{"key":"key\n\t\t\t\t20171012170343_BIB12","unstructured":"De Groot K, Gross WL, Herlyn K, Reinhold-Keller E. Development and validation of a disease extent index for Wegener's granulomatosis. Clin Nephrol2001; 55: 31\u201338"},{"key":"key\n\t\t\t\t20171012170343_BIB13","unstructured":"Luqmani RA, Bacon PA, Moots RJ et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM1994; 87: 671\u2013678"},{"key":"key\n\t\t\t\t20171012170343_BIB14","doi-asserted-by":"crossref","unstructured":"Jayne DR, Rasmussen N. Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group. Mayo Clin Proc1997; 72: 737\u2013747","DOI":"10.1016\/S0025-6196(11)63594-5"},{"key":"key\n\t\t\t\t20171012170343_BIB15","unstructured":"The Laboratories Fournier LF 15-0195 Vasculitis Study Group. Efficacy and safety of LF 15-0195 (anisperimus) in persistent or relapsing primary systemic vasculitis. Cleve Clin J Med2002; 69 [Suppl 2]: SII 191"},{"key":"key\n\t\t\t\t20171012170343_BIB16","doi-asserted-by":"crossref","unstructured":"Diegel ML, Nadler SG, Kiener PA. In vivo administration of 15-deoxyspergulin inhibits antigen-presenting cell stimulation of T cells and NF-kappaB activation. Int Immunopharmacol2002; 2: 1451\u20131464","DOI":"10.1016\/S1567-5769(02)00090-5"},{"key":"key\n\t\t\t\t20171012170343_BIB17","doi-asserted-by":"crossref","unstructured":"Specks U, Fervenza FC, McDonald TJ, Hogan MC. Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum2001; 44: 2836\u20132840","DOI":"10.1002\/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W"},{"key":"key\n\t\t\t\t20171012170343_BIB18","doi-asserted-by":"crossref","unstructured":"Booth A, Harper L, Hammad T et al. Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol2004; 15: 717\u2013721","DOI":"10.1097\/01.ASN.0000114554.67106.28"},{"key":"key\n\t\t\t\t20171012170343_BIB19","doi-asserted-by":"crossref","unstructured":"Tamura K, Niitani H, Oguro M et al. Phase I study of NKT-01. Cancer Chemother Pharmacol1995; 36: 189\u2013194","DOI":"10.1007\/BF00685845"},{"key":"key\n\t\t\t\t20171012170343_BIB20","unstructured":"Amemiya H, Taguchi Y, Fukao K et al. Establishment of rejection therapy with deoxyspergualin by multicentral controlled clinical studies in renal recipients. Transplant Proc1993; 25: 730\u2013733"},{"key":"key\n\t\t\t\t20171012170343_BIB21","unstructured":"Jiang H, Takahara S, Takano Y et al. Experience with administration of 15-deoxyspergualin in rejection in kidney transplant recipients. Transplant Proc1992; 24: 1726\u20131729"},{"key":"key\n\t\t\t\t20171012170343_BIB22","unstructured":"Ohlman S, Gannedahl G, Tyden G, Tufveson G, Groth CG. Treatment of renal transplant rejection with 15-deoxyspergualin \u2013 a dose-finding study in man. Transplant Proc1992; 24: 318\u2013320"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/20\/6\/1083\/5148148\/gfh763.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T22:28:48Z","timestamp":1683066528000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/20\/6\/1083\/1818904\/Prolonged-treatment-of-refractory-Wegeners"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,12]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,4,12]]},"published-print":{"date-parts":[[2005,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfh763","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,6]]},"published":{"date-parts":[[2005,4,12]]}}}